Ontology highlight
ABSTRACT:
SUBMITTER: Loberto N
PROVIDER: S-EPMC4139313 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
Loberto Nicoletta N Tebon Maela M Lampronti Ilaria I Marchetti Nicola N Aureli Massimo M Bassi Rosaria R Giri Maria Grazia MG Bezzerri Valentino V Lovato Valentina V Cantù Cinzia C Munari Silvia S Cheng Seng H SH Cavazzini Alberto A Gambari Roberto R Sonnino Sandro S Cabrini Giulio G Dechecchi Maria Cristina MC
PloS one 20140820 8
Current anti-inflammatory strategies for the treatment of pulmonary disease in cystic fibrosis (CF) are limited; thus, there is continued interest in identifying additional molecular targets for therapeutic intervention. Given the emerging role of sphingolipids (SLs) in various respiratory disorders, including CF, drugs that selectively target the enzymes associated with SL metabolism are under development. Miglustat, a well-characterized iminosugar-based inhibitor of β-glucosidase 2 (GBA2), has ...[more]